← Eichor
Condition: Fibroblast Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Fibroblast

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

[68Ga]Ga-FAPI-46 in Staging of Head and Neck Carcinomas
Phase 2 · 1 location(s) · John O. Prior · NCT06794372Phase III Study with an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Adults and Adolescents
Phase 3 · 1 location(s) · CUTISS AG · NCT06745557The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural Mesothelioma
Phase 2 · 1 location(s) · Aalborg University Hospital · NCT06790082Investigating Age Dependence of Fibroblast and Extracellular Matrix Responses to Cross-linked Hyaluronic Acid Filler in
NA · 1 location(s) · University of Michigan · NCT06195605Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC)
Phase 3 · 15 location(s) · SOFIE · NCT07217717Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma
Phase 1/Phase 2 · 1 location(s) · Beijing Biotech · NCT07510815Molecular Imaging of Cancer-associated Fibroblasts in Glioblastoma: a FAPI PET/MR Study.
NA · 1 location(s) · Jules Bordet Institute · NCT07119294A Study on the Anti-Wrinkle Efficacy Assessment and Safety Evaluation of the Cluster of Autologous Dermal Fibroblast on
Phase 1/Phase 2 · 1 location(s) · S.Biomedics Co., Ltd. · NCT04818203Fibroblast Growth Factor 23 and Risk of Cardiac Arrhythmias in Hemodialysis Patients
Phase N/A · 1 location(s) · Antonio Bellasi · NCT06668831Molecular Imaging of FAP Expressing Cancer-associated Fibroblasts in NSCLC Treated With Immune-checkpoint Inhibitors
NA · 1 location(s) · Jules Bordet Institute · NCT0610760868Ga-FAPI-46 PET/CT for Assessing Small Bowel Fibrostenosis in Crohn's Disease
EARLY_Phase 1 · 1 location(s) · Mayo Clinic · NCT0727318818F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis Patients
Phase N/A · 1 location(s) · Children's Hospital Medical Center, Cincinnati · NCT07077213A Post-marketing Observational Study of Tasfygo in Participants With Unresectable Biliary Tract Cancer With Fibroblast G
Phase N/A · 1 location(s) · Eisai Co., Ltd. · NCT06793709Right Ventricular Function Changes After CIED Implantation: The RIGHT-CIED Study
Phase N/A · 1 location(s) · Istanbul University - Cerrahpasa · NCT0727239568Ga-TCR-FAPI PET/CT Guided Precision Surgery for MTC
NA · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT06277180A Study of 68Ga-Fibroblast Activation Protein Inhibitor (FAPI) Positron Emission Tomography in Heart Failure
Phase 2 · 1 location(s) · Mayo Clinic · NCT07083011Use of Existing Fibroblast Cells to Convert to Induced Pluripotent Stem Cells
Phase N/A · 1 location(s) · Hadassah Medical Organization · NCT00801372Analysis of Dermal Fibroblasts and Immune Cells During Systemic Sclerosis
Phase N/A · 1 location(s) · University Hospital, Lille · NCT05273138PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI
Phase 1 · 1 location(s) · Karolinska University Hospital · NCT05172310FiH Safety and Feasibility Study Assessing Intra-articular Administration of aeGF in Patients With Knee Osteoarthritis
Phase 1 · 1 location(s) · Scarcell Therapeutics S.A.S. · NCT06690710The Application of Bovine Basic Fibroblast Growth Factor Gel in the Treatment of Sensitive Skin
NA · 1 location(s) · Shanghai Dermatology Hospital · NCT06516939Gene Therapy Development and Validation for Huntington's Disease Fibro TG-HD
NA · 1 location(s) · University Hospital, Angers · NCT06444217Multicenter Trial Evaluating the Safety and Efficacy of Autologous Volar Fibroblast Injection Into the Terminal Limb of
Phase 2 · 1 location(s) · Major Extremity Trauma Research Consortium · NCT04839497Unravelling Intestinal Fibrosis in Ulcerative Colitis
Phase 2/Phase 3 · 1 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT06604273Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal
Phase 2 · 1 location(s) · Mayo Clinic · NCT05518903A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Ex
Phase 1/Phase 2 · 5 location(s) · Kidney Cancer Research Bureau · NCT07292168A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate,
Phase 1 · 52 location(s) · BeOne Medicines · NCT06625593NCCH2006/MK010 Trial (FORTUNE Trial)
Phase 2 · 7 location(s) · National Cancer Center, Japan · NCT0496286718F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06503146Safety and Anti-Tumor Activity of TYRA-200 in Advanced Cholangiocarcinoma With Activating FGFR2 Gene Alterations
Phase 1 · 4 location(s) · Tyra Biosciences, Inc · NCT06160752
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.